Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    • July 2025
    • 2025 National Egg and Poultry Awards finalists supplement
    • June 2025
    • 2025 Innovation supplement
    • May 2025
    • April 2025
    • March 2025
    • 2025 Feed and Nutrition supplement
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • 2024 Building for the Future supplement
    • August 2024
    • 2024 Poultry Health supplement
    • July 2024
    • 2024 National Egg and Poultry Awards finalists supplement
    • June 2024
    • 2024 Innovation supplement
    • Pig & Poultry Fair 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • Processing Equipment Supplement – Nov 2023
    • October 2023
    • Building Supplement – Sept 2023
    • September 2023
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
  • FREE Email Newsletters
  • About Us
  • Advertise
  • Subscribe
  • Contact Us
Twitter LinkedIn
Podcast
Poultry News
  • Production
    • Broiler Production
    • Ducks
    • Egg Production
    • Game
    • Hatching
    • Housing
    • Turkeys
  • Processing
  • Business & Politics
    • Business
    • Economics
    • EU & Politics
    • Marketing
    • People
    • Training & Education
  • Welfare
    • Environment
    • Food Safety
    • Vet & Medication
    • Welfare
  • Feed
  • Genetics
  • New Products
  • Magazines
    1. July 2025
    2. 2025 National Egg and Poultry Awards finalists supplement
    3. June 2025
    4. 2025 Innovation supplement
    5. May 2025
    6. April 2025
    7. March 2025
    8. 2025 Feed and Nutrition supplement
    9. February 2025
    10. January 2025
    11. December 2024
    12. November 2024
    13. October 2024
    14. September 2024
    15. 2024 Building for the Future supplement
    16. August 2024
    17. 2024 Poultry Health supplement
    18. July 2024
    19. 2024 National Egg and Poultry Awards finalists supplement
    20. June 2024
    21. 2024 Innovation supplement
    22. Pig & Poultry Fair 2024
    23. May 2024
    24. April 2024
    25. March 2024
    26. February 2024
    27. January 2024
    28. December 2023
    29. November 2023
    30. Processing Equipment Supplement – Nov 2023
    31. October 2023
    32. Building Supplement – Sept 2023
    33. September 2023
    Featured

    Poultry Business – July 2025 issue

    By Chloe RyanJuly 1, 2025
    Recent

    Poultry Business – July 2025 issue

    July 1, 2025

    Poultry Business – 2025 National Egg and Poultry Awards finalists supplement

    July 1, 2025

    Poultry Business – June 2025 issue

    June 9, 2025
  • Jobs
    • Browse Jobs
    • Post a Job
    • Manage Jobs
  • Events
    • National Egg and Poultry Awards
    • Poultry Fair
    • Webinars
Twitter LinkedIn
Poultry News
Health & Welfare

Significant Brexit-based staff loss prompts EMA scale back

Colin LeyBy Colin LeyAugust 2, 20183 Mins Read
Facebook Twitter LinkedIn Email
Share
Facebook Twitter LinkedIn Email

The European Medicines Agency (EMA) is to temporarily scale back and suspend certain activities ahead of its Brexit-based relocation to Amsterdam in March 2019.

As a result, EMA’s engagement in global health issues such as antimicrobial resistance or vaccines will be ‘maintained as long as possible, but reviewed on a case-by-case basis’.

The Agency has said it will safeguard core activities related to the evaluation and supervision of medicines, while it intensifies its preparations for the physical move to Amsterdam in March 2019 and copes with significant staff loss.

“The temporary cuts in activities are required because it has also become clear that the Agency will lose more staff than initially anticipated,” stated EMA. “Staff who will not relocate to Amsterdam have already started to leave the Agency and this trend is expected to accelerate.

“In addition, due to the employment rules in the Netherlands, 135 short-term contract staff will no longer be able to work for EMA. Overall, EMA expects a staff loss of about 30%, with a high degree of uncertainty regarding mid-term staff retention.

“EMA has put in place supporting measures to facilitate the relocation of staff to Amsterdam and additional support is provided by the Dutch government. Other mitigating actions, such as a comprehensive staff recruitment programme, are already underway. However, in the short- to mid-term EMA will have to reprioritise its resources to fully maintain its core activities related to the evaluation and supervision of medicines to the level of quality and within the timelines expected.”

EMA activities initially impacted during the ‘scale-back’ include:

  • Collaboration at international level, which will be temporarily scaled back to focus primarily on product-related requests, supply-chain integrity and procedures under Article 58; in other areas, such as the harmonisation of global medicine regulation, EMA will only take a reactive role; EMA’s engagement in other global public health issues such as antimicrobial resistance or vaccines will be maintained as long as possible, but reviewed on a case-by-case basis;
  • Development and revision of guidelines, which will be temporarily limited to those guidelines that address an urgent public/animal health need or are necessary to support and facilitate preparations for Brexit;
  • Holding of non-product-related working parties, which will be temporarily reduced as a consequence of the scaling back of guideline development or revision;
  • Programmes and projects, where activities in relation to project governance will be reduced in line with the reduction/suspension of projects;
  • Organisation and attendance at stakeholder meetings, which will be limited to Brexit-related interactions;
  • Clinical data publication, for which the launch of new procedures will be temporarily suspended as of 1 August 2018; data packages submitted for medicines until the end of July 2018 will be processed and finalised.

EMA said that the implementation date for the scale-back is 1 October at the latest.

“Detailed plans for the implementation of these measures are currently being developed and will be communicated to stakeholders concerned and the public as soon as they are available,” it added.

Share. Facebook Twitter LinkedIn Email
Previous Article2018 Pig & Poultry Fair was ‘best yet’
Next Article NFU thanks Richard and Amy for Eggucation idea
Colin Ley

Read Similar Stories

Health & Welfare

Comment: Why I still believe the Better Chicken Commitment has a future

July 14, 20254 Mins Read
Health & Welfare

EFSA warns of bird migration and US imports pathways for AI into Europe

July 11, 20252 Mins Read
Health & Welfare

Tackling red mite

July 4, 20254 Mins Read
Latest News

Wyreside rebrands as Innovad Group

July 15, 2025

Comment: Why I still believe the Better Chicken Commitment has a future

July 14, 2025

Comment: A cautious welcome for Defra’s spending plans

July 14, 2025
Sponsored Content

Navigating Sustainability in Egg Production: Practical Steps for Producers

June 1, 2025

Maintain stable and continuous coccidiosis control amidst stocking density reductions

November 1, 2024
© 2024 MA Agriculture Ltd, a Mark Allen Group company

Privacy Policy | Cookies Policy | Terms & Conditions

  • Farmers Weekly
  • AA Farmer
  • Farm Contractor
  • Pig World

Type above and press Enter to search. Press Esc to cancel.